Long noncoding RNA dysregulation in ischemic heart failure S Greco, G Zaccagnini, A Perfetti, P Fuschi, R Valaperta, C Voellenkle, ... Journal of translational medicine 14, 1-14, 2016 | 207 | 2016 |
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing C Voellenkle, JM Garcia-Manteiga, S Pedrotti, A Perfetti, I De Toma, ... Scientific reports 6 (1), 24141, 2016 | 141 | 2016 |
Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia G Zaccagnini, B Maimone, V Di Stefano, P Fasanaro, S Greco, A Perfetti, ... Antioxidants & redox signaling 21 (8), 1177-1188, 2014 | 109 | 2014 |
Deregulated microRNAs in myotonic dystrophy type 2 S Greco, A Perfetti, P Fasanaro, R Cardani, MC Capogrossi, G Meola, ... PloS one 7 (6), e39732, 2012 | 105 | 2012 |
Plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, E Bugiardini, R Cardani, P Gaia, C Gaetano, G Meola, ... Neuromuscular Disorders 24 (6), 509-515, 2014 | 84 | 2014 |
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, R Cardani, B Fossati, G Cuomo, R Valaperta, ... Scientific reports 6 (1), 38174, 2016 | 66 | 2016 |
Dysregulation of circular RNAs in myotonic dystrophy type 1 C Voellenkle, A Perfetti, M Carrara, P Fuschi, LV Renna, M Longo, ... International journal of molecular sciences 20 (8), 1938, 2019 | 34 | 2019 |
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 A Perfetti, S Greco, P Fasanaro, E Bugiardini, R Cardani, JMG Manteiga, ... PloS one 9 (4), e93983, 2014 | 33 | 2014 |
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2 M Cappella, A Perfetti, B Cardinali, JM Garcia-Manteiga, M Carrara, ... Cell death & disease 9 (7), 729, 2018 | 23 | 2018 |
Noncoding RNAs: emerging players in muscular dystrophies G Falcone, A Perfetti, B Cardinali, F Martelli BioMed Research International 2014, 2014 | 21 | 2014 |
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods: a useful tool in myotonic dystrophy type 1 S Iachettini, R Valaperta, A Marchesi, A Perfetti, G Cuomo, B Fossati, ... European Journal of Histochemistry: EJH 59 (4), 2015 | 8 | 2015 |
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene B Cardinali, C Provenzano, M Izzo, C Voellenkle, J Battistini, ... Molecular Therapy-Nucleic Acids 27, 184-199, 2022 | 7 | 2022 |
Implication of long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep 6: 24141 C Voellenkle, JM Garcia-Manteiga, S Pedrotti, A Perfetti, I De Toma, ... | 4 | 2016 |
Heart failure modulates long noncoding RNA expression in human left ventricles S Greco, A Perfetti, L Menicanti, S Castelvecchio, F Martelli European Heart Journal 34 (suppl_1), P3250, 2013 | 3 | 2013 |
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 (vol 4, 38174, 2016) A Perfetti, S Greco, R Cardani, B Fossati, G Cuomo, R Valaperta, ... SCIENTIFIC REPORTS 7, 2017 | 1 | 2017 |
Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, R Cardani, B Fossati, G Cuomo, R Valaperta, ... Scientific Reports 7, 2017 | 1 | 2017 |
Anabolic steroid nandrolone acugments hepatic regenerative response in rats P Sileri, G Palmieri, P Gentileschi, A Perfetti, G Sica, M Venza, D Benavoli, ... TRANSPLANTATION PROCEEDINGS 37, 6-4563, 2005 | 1 | 2005 |
Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 G Falcone, M Izzo, B Cardinali, J Battistini, S Mandillo, E Golini, ... Myology, 2022 | | 2022 |
SKELETAL MUSCLE AND CIRCULATING MICRORNAS IN MYOTONIC DISTROPHY TYPE 1 A Perfetti Università degli Studi di Milano, 2017 | | 2017 |
Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic A Perfetti, S Greco, P Fasanaro, E Bugiardini, R Cardani | | 2014 |